Merit Medical Systems (MMSI) Stock Forecast & Price Target

Compare

331 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMSI Analyst Ratings

Strong Buy

9 Buy

1 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Merit

Medical Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMSI Stock 12 Month Forecast

Average Price Target

$108.80

▲(27.91%Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Merit Medical Systems in the last 3 months. The average price target is $108.80 with a high forecast of $122.00 and a low forecast of $100.00. The average price target represents a 27.91% change from the last price of $85.06.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"80":"$80","123":"$123","90.75":"$90.8","101.5":"$101.5","112.25":"$112.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":122,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$122.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":108.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$108.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$100.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[80,90.75,101.5,112.25,123],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.98,96.13538461538462,98.29076923076923,100.44615384615385,102.60153846153847,104.75692307692307,106.91230769230769,109.06769230769231,111.22307692307692,113.37846153846154,115.53384615384616,117.68923076923076,119.84461538461538,{"y":122,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.98,95.12,96.26,97.4,98.54,99.68,100.82,101.96,103.1,104.24,105.38,106.52,107.66,{"y":108.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,93.98,94.44307692307693,94.90615384615386,95.36923076923077,95.8323076923077,96.29538461538462,96.75846153846155,97.22153846153846,97.68461538461538,98.14769230769231,98.61076923076924,99.07384615384615,99.53692307692307,{"y":100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":81.15,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.64,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.12,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.68,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.61,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.83,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.72,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.64,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.98,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$122.00

Average Price Target$108.80

Lowest Price Target$100.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$91

Hold

6.98%

Upside

Downgraded

07/17/25

Merit Medical Systems' strong financial performance and strategic acquisitions are key strengths, but bearish technical indicators and valuation concerns weigh down the score. The company's positive guidance and corporate events support a cautiously optimistic outlook.

Michael MatsonNeedham

Needham

$108

Buy

26.97%

Upside

Reiterated

07/18/25

Buy Rating for Merit Medical Systems Driven by WRAPSODY Product Launch and Strategic Pricing

Larry BiegelsenWells Fargo

Wells Fargo

$108

Buy

26.97%

Upside

Reiterated

07/16/25

Merit Medical confirms Wrapsody pass-through denied, says Wells FargoMerit Medical confirms Wrapsody pass-through denied, says Wells Fargo

David RescottRobert W. Baird

Robert W. Baird

$110→$112

Buy

31.67%

Upside

Reiterated

07/16/25

Robert W. Baird Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

John Young CFACanaccord Genuity

Canaccord Genuity

$112

Buy

31.67%

Upside

Reiterated

07/16/25

Canaccord Genuity Remains a Buy on Merit Medical Systems (MMSI)

Jayson BedfordRaymond James

Raymond James

$91.12→$108

Buy

26.97%

Upside

Reiterated

07/08/25

Raymond James Remains a Buy on Merit Medical Systems (MMSI)

James SidotiSidoti

Sidoti

$122

Buy

43.43%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI) and Soleno Therapeutics (NASDAQ: SLNO)

Jason BednarPiper Sandler

Piper Sandler

$110

Buy

29.32%

Upside

Reiterated

07/08/25

Piper Sandler Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

Craig BijouBank of America Securities

Bank of America Securities

$100

Hold

17.56%

Upside

Reiterated

07/07/25

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

Robbie MarcusJ.P. Morgan

J.P. Morgan

$120→$105

Buy

23.44%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Merit Medical Systems (NASDAQ: MMSI)

Michael PetuskyBarrington

Barrington

$111→$103

Buy

21.09%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF) and Merit Medical Systems (NASDAQ: MMSI)

Steven LichtmanOppenheimer

Oppenheimer

$120→$116

Buy

36.37%

Upside

Reiterated

02/26/25

Merit Medical Systems, Inc. (MMSI) PT Lowered to $116 at OppenheimerOppenheimer analyst Steven Lichtman lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $116.00 (from $120.00) while maintaining a Outperform rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$91

Hold

6.98%

Upside

Downgraded

07/17/25

Michael MatsonNeedham

Needham

$108

Buy

26.97%

Upside

Reiterated

07/18/25

Buy Rating for Merit Medical Systems Driven by WRAPSODY Product Launch and Strategic Pricing

Larry BiegelsenWells Fargo

Wells Fargo

$108

Buy

26.97%

Upside

Reiterated

07/16/25

Merit Medical confirms Wrapsody pass-through denied, says Wells FargoMerit Medical confirms Wrapsody pass-through denied, says Wells Fargo

David RescottRobert W. Baird

Robert W. Baird

$110→$112

Buy

31.67%

Upside

Reiterated

07/16/25

Robert W. Baird Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

John Young CFACanaccord Genuity

Canaccord Genuity

$112

Buy

31.67%

Upside

Reiterated

07/16/25

Canaccord Genuity Remains a Buy on Merit Medical Systems (MMSI)

Jayson BedfordRaymond James

Raymond James

$91.12→$108

Buy

26.97%

Upside

Reiterated

07/08/25

Raymond James Remains a Buy on Merit Medical Systems (MMSI)

James SidotiSidoti

Sidoti

$122

Buy

43.43%

Upside

Reiterated

07/08/25

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (NASDAQ: MMSI) and Soleno Therapeutics (NASDAQ: SLNO)

Jason BednarPiper Sandler

Piper Sandler

$110

Buy

29.32%

Upside

Reiterated

07/08/25

Piper Sandler Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

Craig BijouBank of America Securities

Bank of America Securities

$100

Hold

17.56%

Upside

Reiterated

07/07/25

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

Robbie MarcusJ.P. Morgan

J.P. Morgan

$120→$105

Buy

23.44%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Merit Medical Systems (NASDAQ: MMSI)

Michael PetuskyBarrington

Barrington

$111→$103

Buy

21.09%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF) and Merit Medical Systems (NASDAQ: MMSI)

Steven LichtmanOppenheimer

Oppenheimer

$120→$116

Buy

36.37%

Upside

Reiterated

02/26/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merit Medical Systems

1 Month

xxx

Success Rate

23/32 ratings generated profit

Average Return

+4.39%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.88% of your transactions generating a profit, with an average return of +4.39% per trade.

3 Months

xxx

Success Rate

26/32 ratings generated profit

Average Return

+10.01%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 81.25% of your transactions generating a profit, with an average return of +10.01% per trade.

1 Year

Jayson BedfordRaymond James

Success Rate

21/32 ratings generated profit

Average Return

+21.62%

reiterated a buy rating 17 days ago

Copying Jayson Bedford's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +21.62% per trade.

2 Years

xxx

Success Rate

20/32 ratings generated profit

Average Return

+19.16%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +19.16% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMSI Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMSI has received 20 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. MMSI average Analyst price target in the past 3 months is 108.80.

Each month's total comprises the sum of three months' worth of ratings.

MMSI Financial Forecast

MMSI Earnings Forecast

Next quarter’s earnings estimate for MMSI is $0.85 with a range of $0.83 to $0.88. The previous quarter’s EPS was $0.86. MMSI beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year MMSI has Preformed in-line its overall industry.

MMSI Sales Forecast

Next quarter’s sales forecast for MMSI is $374.16M with a range of $369.64M to $382.00M. The previous quarter’s sales results were $354.33M. MMSI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.59% of the time in the same period. In the last calendar year MMSI has Preformed in-line its overall industry.

MMSI Stock Forecast FAQ

What is MMSI’s average 12-month price target, according to analysts?

Based on analyst ratings, Merit Medical’s 12-month average price target is 108.80.

What is MMSI’s upside potential, based on the analysts’ average price target?

Merit Medical has 27.91% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMSI a Buy, Sell or Hold?

Merit Medical has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.

What is Merit Medical’s price target?

The average price target for Merit Medical is 108.80. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $122.00 ,the lowest forecast is $100.00. The average price target represents 27.91% Increase from the current price of $85.06.

What do analysts say about Merit Medical?

Merit Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of MMSI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Merit Medical Systems (MMSI) Stock Forecast & Price Target

MMSI Analyst Ratings

MMSI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Merit Medical Systems

MMSI Analyst Recommendation Trends

MMSI Financial Forecast

MMSI Earnings Forecast

MMSI Sales Forecast

MMSI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts